S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

Detalles Bibliográficos
Autores principales: Mateos, Maria-Victoria, Morillo, Daniel, Gatt, Moshe, Sebag, Michael, Kim, Kihyun, Min, Chang-Ki, Oriol, Albert, Ocio, Enrique, Yoon, Sung-Soo, Cohen, Yael, Chu, Michael, Rodríguez-Otero, Paula, Avivi, Irit, Guo, Yue, Krevvata, Maria, Peterson, Michelle, Beelen, Melissa, Vanak, Jill, Banerjee, Arnob, Magen, Hila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428427/
http://dx.doi.org/10.1097/01.HS9.0000967672.15362.d7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428427/
http://dx.doi.org/10.1097/01.HS9.0000967672.15362.d7

Ejemplares similares